HGP-30: The companies' Viral Technologies Inc. joint venture began an extension of a Phase I trial, for safely and to monitor immune memory responses in 15 HIV-

Alpha 1 Biomedicals Inc. (ALBM), Bethesda, Md.
Cel-Sci Corp.

Read the full 109 word article

How to gain access

Continue reading with a
two-week free trial.